Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2796301000168112 | Metastron (strontium (89Sr) chloride 150 MBq / 4 mL) injection, 4 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2796311000168110 | Metastron 150 MBq/4 mL injection, 4 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Metastron 150 MBq/4 mL injection, 4 mL vial | Is a | Metastron | true | Inferred relationship | Some | ||
| Metastron 150 MBq/4 mL injection, 4 mL vial | Is a | strontium (89Sr) chloride 150 MBq/4 mL injection, vial | true | Inferred relationship | Some | ||
| Metastron 150 MBq/4 mL injection, 4 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Metastron 150 MBq/4 mL injection, 4 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Metastron 150 MBq/4 mL injection, 4 mL vial | has unit of use | vial | true | Inferred relationship | Some | 497425093 | |
| Metastron 150 MBq/4 mL injection, 4 mL vial | has intended active ingredient | strontium (89Sr) | true | Inferred relationship | Some | 497425092 | |
| Metastron 150 MBq/4 mL injection, 4 mL vial | has Australian BoSS | strontium (89Sr) chloride | true | Inferred relationship | Some | 497425092 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Metastron 150 MBq/4 mL injection, 4 mL vial | has TPUU | True | Metastron 150 MBq/4 mL injection, 4 mL vial | Inferred relationship | Some | 1 |
| Metastron 150 MBq/4 mL injection, 4 mL vial | has TPUU | True | Metastron 150 MBq/4 mL injection, 4 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR